CA3006793C - Non-small cell lung cancer biomarkers and uses thereof - Google Patents

Info

Publication number

CA3006793C

CA3006793C CA3006793A CA3006793A CA3006793C CA 3006793 C CA3006793 C CA 3006793C CA 3006793 A CA3006793 A CA 3006793A CA 3006793 A CA3006793 A CA 3006793A CA 3006793 C CA3006793 C CA 3006793C

Authority

CA

Canada

Prior art keywords

biomarkers

biomarker

individual

nsclc

cancer

Prior art date

2011-10-24

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Active

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 208000002154 non-small cell lung carcinoma Diseases 0.000 title claims abstract description 262
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 title claims abstract description 262
• 239000000107 tumor biomarker Substances 0.000 title description 19
• 239000000090 biomarker Substances 0.000 claims abstract description 756
• 238000000034 method Methods 0.000 claims abstract description 326
• 239000012472 biological sample Substances 0.000 claims abstract description 111
• 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 56
• 102100032765 Chordin-like protein 1 Human genes 0.000 claims abstract description 21
• 101000941971 Homo sapiens Chordin-like protein 1 Proteins 0.000 claims abstract description 21
• 108091023037 Aptamer Proteins 0.000 claims description 142
• 108090000623 proteins and genes Proteins 0.000 claims description 90
• 102000004169 proteins and genes Human genes 0.000 claims description 75
• 238000003556 assay Methods 0.000 claims description 53
• 230000002685 pulmonary effect Effects 0.000 claims description 24
• 210000004072 lung Anatomy 0.000 claims description 21
• 238000012216 screening Methods 0.000 claims description 20
• 210000004369 blood Anatomy 0.000 claims description 15
• 239000008280 blood Substances 0.000 claims description 15
• 210000002966 serum Anatomy 0.000 claims description 11
• 210000002381 plasma Anatomy 0.000 claims description 8
• 238000001514 detection method Methods 0.000 abstract description 56
• 208000020816 lung neoplasm Diseases 0.000 abstract description 35
• 201000005202 lung cancer Diseases 0.000 abstract description 30
• 206010058467 Lung neoplasm malignant Diseases 0.000 abstract description 29
• 238000003745 diagnosis Methods 0.000 abstract description 27
• 102100030417 Matrilysin Human genes 0.000 description 345
• 101000990912 Homo sapiens Matrilysin Proteins 0.000 description 344
• 102100034667 Chloride intracellular channel protein 1 Human genes 0.000 description 189
• 101000946430 Homo sapiens Chloride intracellular channel protein 1 Proteins 0.000 description 189
• 102100029932 Syntaxin-1A Human genes 0.000 description 182
• 101000585070 Homo sapiens Syntaxin-1A Proteins 0.000 description 178
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 165
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 165
• 239000000523 sample Substances 0.000 description 155
• 206010028980 Neoplasm Diseases 0.000 description 136
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 117
• 201000010099 disease Diseases 0.000 description 116
• 201000011510 cancer Diseases 0.000 description 113
• 102100027832 14-3-3 protein gamma Human genes 0.000 description 103
• 101000723517 Homo sapiens 14-3-3 protein gamma Proteins 0.000 description 103
• 239000003550 marker Substances 0.000 description 74
• 238000012360 testing method Methods 0.000 description 65
• 101000979623 Homo sapiens Nucleoside diphosphate kinase B Proteins 0.000 description 63
• 101000829705 Methanopyrus kandleri (strain AV19 / DSM 6324 / JCM 9639 / NBRC 100938) Thermosome subunit Proteins 0.000 description 63
• 102100023258 Nucleoside diphosphate kinase B Human genes 0.000 description 63
• 239000013625 clathrin-independent carrier Substances 0.000 description 63
• 101001017855 Homo sapiens Leucine-rich repeats and immunoglobulin-like domains protein 3 Proteins 0.000 description 61
• 102100033284 Leucine-rich repeats and immunoglobulin-like domains protein 3 Human genes 0.000 description 61
• 210000004027 cell Anatomy 0.000 description 59
• 210000001519 tissue Anatomy 0.000 description 59
• 230000014509 gene expression Effects 0.000 description 52
• 230000008569 process Effects 0.000 description 49
• 238000011282 treatment Methods 0.000 description 47
• 230000000875 corresponding effect Effects 0.000 description 40
• 239000000243 solution Substances 0.000 description 37
• 238000002591 computed tomography Methods 0.000 description 36
• 150000007523 nucleic acids Chemical class 0.000 description 36
• 102000039446 nucleic acids Human genes 0.000 description 35
• 108020004707 nucleic acids Proteins 0.000 description 35
• 239000007787 solid Substances 0.000 description 35
• 101000894525 Homo sapiens Transforming growth factor-beta-induced protein ig-h3 Proteins 0.000 description 34
• 102100021398 Transforming growth factor-beta-induced protein ig-h3 Human genes 0.000 description 34
• 238000004590 computer program Methods 0.000 description 34
• 230000035945 sensitivity Effects 0.000 description 34
• 101000983170 Homo sapiens Proliferation-associated protein 2G4 Proteins 0.000 description 32
• 102100026899 Proliferation-associated protein 2G4 Human genes 0.000 description 32
• 230000006870 function Effects 0.000 description 27
• 238000003384 imaging method Methods 0.000 description 27
• 229920001213 Polysorbate 20 Polymers 0.000 description 26
• 238000004458 analytical method Methods 0.000 description 26
• 238000002790 cross-validation Methods 0.000 description 26
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 26
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 26
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
• 206010054107 Nodule Diseases 0.000 description 25
• 238000012549 training Methods 0.000 description 24
• 102000012005 alpha-2-HS-Glycoprotein Human genes 0.000 description 23
• 108010075843 alpha-2-HS-Glycoprotein Proteins 0.000 description 23
• 239000012491 analyte Substances 0.000 description 23
• 239000000203 mixture Substances 0.000 description 23
• 238000010186 staining Methods 0.000 description 23
• 101000801742 Homo sapiens Triosephosphate isomerase Proteins 0.000 description 22
• 102100033598 Triosephosphate isomerase Human genes 0.000 description 22
• 101000609413 Homo sapiens Inter-alpha-trypsin inhibitor heavy chain H4 Proteins 0.000 description 21
• 102100039457 Inter-alpha-trypsin inhibitor heavy chain H4 Human genes 0.000 description 21
• 238000013459 approach Methods 0.000 description 21
• 239000011324 bead Substances 0.000 description 21
• 239000000463 material Substances 0.000 description 21
• 102100024539 Chymase Human genes 0.000 description 19
• 239000002609 medium Substances 0.000 description 19
• 238000012163 sequencing technique Methods 0.000 description 19
• 101000909983 Homo sapiens Chymase Proteins 0.000 description 18
• 210000000988 bone and bone Anatomy 0.000 description 18
• 238000002405 diagnostic procedure Methods 0.000 description 18
• 238000009826 distribution Methods 0.000 description 18
• 238000012545 processing Methods 0.000 description 18
• 239000000872 buffer Substances 0.000 description 17
• 238000009396 hybridization Methods 0.000 description 17
• 238000001356 surgical procedure Methods 0.000 description 17
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 16
• 230000001419 dependent effect Effects 0.000 description 16
• 230000004044 response Effects 0.000 description 16
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 15
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
• 238000004422 calculation algorithm Methods 0.000 description 15
• -1 methods Substances 0.000 description 15
• 101000653679 Homo sapiens Translationally-controlled tumor protein Proteins 0.000 description 14
• 102100029887 Translationally-controlled tumor protein Human genes 0.000 description 14
• 239000003795 chemical substances by application Substances 0.000 description 14
• 238000011156 evaluation Methods 0.000 description 14
• 239000003001 serine protease inhibitor Substances 0.000 description 14
• ZBZXYUYUUDZCNB-UHFFFAOYSA-N N-cyclohexa-1,3-dien-1-yl-N-phenyl-4-[4-(N-[4-[4-(N-[4-[4-(N-phenylanilino)phenyl]phenyl]anilino)phenyl]phenyl]anilino)phenyl]aniline Chemical compound C1=CCCC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 ZBZXYUYUUDZCNB-UHFFFAOYSA-N 0.000 description 13
• 238000009739 binding Methods 0.000 description 13
• 230000001965 increasing effect Effects 0.000 description 13
• 238000004949 mass spectrometry Methods 0.000 description 13
• 238000005259 measurement Methods 0.000 description 13
• 125000003729 nucleotide group Chemical group 0.000 description 13
• 238000002360 preparation method Methods 0.000 description 13
• 229920001817 Agar Polymers 0.000 description 12
• 102100025805 Cadherin-1 Human genes 0.000 description 12
• 108091007854 Cdh1/Fizzy-related Proteins 0.000 description 12
• 102000004190 Enzymes Human genes 0.000 description 12
• 108090000790 Enzymes Proteins 0.000 description 12
• 239000008272 agar Substances 0.000 description 12
• 230000027455 binding Effects 0.000 description 12
• 238000005516 engineering process Methods 0.000 description 12
• 229940088598 enzyme Drugs 0.000 description 12
• 238000003018 immunoassay Methods 0.000 description 12
• 108090000765 processed proteins & peptides Proteins 0.000 description 12
• 238000003860 storage Methods 0.000 description 12
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
• 108091034117 Oligonucleotide Proteins 0.000 description 11
• 206010056342 Pulmonary mass Diseases 0.000 description 11
• 238000001574 biopsy Methods 0.000 description 11
• 239000011521 glass Substances 0.000 description 11
• 230000004048 modification Effects 0.000 description 11
• 238000012986 modification Methods 0.000 description 11
• 239000000047 product Substances 0.000 description 11
• 150000001413 amino acids Chemical group 0.000 description 10
• 229960002685 biotin Drugs 0.000 description 10
• 239000011616 biotin Substances 0.000 description 10
• 239000003446 ligand Substances 0.000 description 10
• 239000002679 microRNA Substances 0.000 description 10
• 238000002493 microarray Methods 0.000 description 10
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
• 238000006243 chemical reaction Methods 0.000 description 9
• 230000002380 cytological effect Effects 0.000 description 9
• 239000003814 drug Substances 0.000 description 9
• 239000000975 dye Substances 0.000 description 9
• 239000000834 fixative Substances 0.000 description 9
• 238000010438 heat treatment Methods 0.000 description 9
• 108091070501 miRNA Proteins 0.000 description 9
• 238000012544 monitoring process Methods 0.000 description 9
• 102000004196 processed proteins & peptides Human genes 0.000 description 9
• 108090000654 Bone morphogenetic protein 1 Proteins 0.000 description 8
• 238000007792 addition Methods 0.000 description 8
• 230000008901 benefit Effects 0.000 description 8
• 230000000903 blocking effect Effects 0.000 description 8
• 230000000694 effects Effects 0.000 description 8
• 210000001165 lymph node Anatomy 0.000 description 8
• 108020004999 messenger RNA Proteins 0.000 description 8
• 238000003199 nucleic acid amplification method Methods 0.000 description 8
• 229940124597 therapeutic agent Drugs 0.000 description 8
• 238000002560 therapeutic procedure Methods 0.000 description 8
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
• 102000004152 Bone morphogenetic protein 1 Human genes 0.000 description 7
• 108020004414 DNA Proteins 0.000 description 7
• 101001097889 Homo sapiens Platelet-activating factor acetylhydrolase Proteins 0.000 description 7
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 7
• 102100037518 Platelet-activating factor acetylhydrolase Human genes 0.000 description 7
• 230000002159 abnormal effect Effects 0.000 description 7
• 235000020958 biotin Nutrition 0.000 description 7
• 238000004364 calculation method Methods 0.000 description 7
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 7
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 7
• 239000012530 fluid Substances 0.000 description 7
• 239000012634 fragment Substances 0.000 description 7
• 239000000499 gel Substances 0.000 description 7
• 238000001727 in vivo Methods 0.000 description 7
• 230000003211 malignant effect Effects 0.000 description 7
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 7
• 239000002773 nucleotide Substances 0.000 description 7
• 210000000056 organ Anatomy 0.000 description 7
• 239000008188 pellet Substances 0.000 description 7
• 229920001184 polypeptide Polymers 0.000 description 7
• 239000008096 xylene Substances 0.000 description 7
• 101100242304 Arabidopsis thaliana GCP1 gene Proteins 0.000 description 6
• 101100412054 Arabidopsis thaliana RD19B gene Proteins 0.000 description 6
• 102100024326 Contactin-1 Human genes 0.000 description 6
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
• 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 description 6
• 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 description 6
• 206010036790 Productive cough Diseases 0.000 description 6
• 101150118301 RDL1 gene Proteins 0.000 description 6
• 230000003321 amplification Effects 0.000 description 6
• 210000000621 bronchi Anatomy 0.000 description 6
• 238000004891 communication Methods 0.000 description 6
• 239000002872 contrast media Substances 0.000 description 6
• 230000007423 decrease Effects 0.000 description 6
• 238000011161 development Methods 0.000 description 6
• 238000005315 distribution function Methods 0.000 description 6
• 230000007170 pathology Effects 0.000 description 6
• 229920000642 polymer Polymers 0.000 description 6
• 230000000391 smoking effect Effects 0.000 description 6
• 210000003802 sputum Anatomy 0.000 description 6
• 208000024794 sputum Diseases 0.000 description 6
• 239000000126 substance Substances 0.000 description 6
• 238000003828 vacuum filtration Methods 0.000 description 6
• 238000005406 washing Methods 0.000 description 6
• 102100028443 Aflatoxin B1 aldehyde reductase member 2 Human genes 0.000 description 5
• 102100036369 Carbonic anhydrase 6 Human genes 0.000 description 5
• 102100035617 Heterogeneous nuclear ribonucleoprotein A/B Human genes 0.000 description 5
• 101000909520 Homo sapiens Contactin-1 Proteins 0.000 description 5
• 101000854036 Homo sapiens Heterogeneous nuclear ribonucleoprotein A/B Proteins 0.000 description 5
• 101000577881 Homo sapiens Macrophage metalloelastase Proteins 0.000 description 5
• 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 description 5
• 102100027998 Macrophage metalloelastase Human genes 0.000 description 5
• 206010027476 Metastases Diseases 0.000 description 5
• 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 description 5
• 108010078976 aflatoxin B1 aldehyde reductase Proteins 0.000 description 5
• 238000002820 assay format Methods 0.000 description 5
• 230000008238 biochemical pathway Effects 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 230000001413 cellular effect Effects 0.000 description 5
• 230000008859 change Effects 0.000 description 5
• 210000000038 chest Anatomy 0.000 description 5
• 230000000295 complement effect Effects 0.000 description 5
• 238000013170 computed tomography imaging Methods 0.000 description 5
• 230000002255 enzymatic effect Effects 0.000 description 5
• 238000002866 fluorescence resonance energy transfer Methods 0.000 description 5
• 239000007850 fluorescent dye Substances 0.000 description 5
• 238000011534 incubation Methods 0.000 description 5
• 230000003993 interaction Effects 0.000 description 5
• 238000002372 labelling Methods 0.000 description 5
• 239000007788 liquid Substances 0.000 description 5
• 239000012528 membrane Substances 0.000 description 5
• 210000004379 membrane Anatomy 0.000 description 5
• 230000015654 memory Effects 0.000 description 5
• 230000003287 optical effect Effects 0.000 description 5
• 239000002245 particle Substances 0.000 description 5
• 238000007637 random forest analysis Methods 0.000 description 5
• 229920005989 resin Polymers 0.000 description 5
• 239000011347 resin Substances 0.000 description 5
• 238000000926 separation method Methods 0.000 description 5
• 239000006228 supernatant Substances 0.000 description 5
• 230000004083 survival effect Effects 0.000 description 5
• 208000024891 symptom Diseases 0.000 description 5
• 102100038238 Aromatic-L-amino-acid decarboxylase Human genes 0.000 description 4
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
• 238000002965 ELISA Methods 0.000 description 4
• 108010067770 Endopeptidase K Proteins 0.000 description 4
• 208000019693 Lung disease Diseases 0.000 description 4
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
• 239000002202 Polyethylene glycol Substances 0.000 description 4
• 208000006265 Renal cell carcinoma Diseases 0.000 description 4
• 108010091769 Shiga Toxin 1 Proteins 0.000 description 4
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
• 206010041067 Small cell lung cancer Diseases 0.000 description 4
• 108010035075 Tyrosine decarboxylase Proteins 0.000 description 4
• 239000008366 buffered solution Substances 0.000 description 4
• 229940000425 combination drug Drugs 0.000 description 4
• 230000009850 completed effect Effects 0.000 description 4
• 230000034994 death Effects 0.000 description 4
• 231100000517 death Toxicity 0.000 description 4
• 238000003795 desorption Methods 0.000 description 4
• 239000003599 detergent Substances 0.000 description 4
• 238000003748 differential diagnosis Methods 0.000 description 4
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 4
• 238000011067 equilibration Methods 0.000 description 4
• 239000000835 fiber Substances 0.000 description 4
• 230000002068 genetic effect Effects 0.000 description 4
• 239000012216 imaging agent Substances 0.000 description 4
• 238000011503 in vivo imaging Methods 0.000 description 4
• 150000002500 ions Chemical class 0.000 description 4
• 230000003902 lesion Effects 0.000 description 4
• 239000011159 matrix material Substances 0.000 description 4
• 230000009401 metastasis Effects 0.000 description 4
• 230000000877 morphologic effect Effects 0.000 description 4
• 230000035699 permeability Effects 0.000 description 4
• 210000004224 pleura Anatomy 0.000 description 4
• 229920001223 polyethylene glycol Polymers 0.000 description 4
• 238000002600 positron emission tomography Methods 0.000 description 4
• 239000013049 sediment Substances 0.000 description 4
• 208000000587 small cell lung carcinoma Diseases 0.000 description 4
• 238000003756 stirring Methods 0.000 description 4
• 238000006467 substitution reaction Methods 0.000 description 4
• 239000000758 substrate Substances 0.000 description 4
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
• 102100022712 Alpha-1-antitrypsin Human genes 0.000 description 3
• 102100031162 Collagen alpha-1(XVIII) chain Human genes 0.000 description 3
• 208000005156 Dehydration Diseases 0.000 description 3
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
• 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 3
• 239000004471 Glycine Substances 0.000 description 3
• 239000007995 HEPES buffer Substances 0.000 description 3
• 101000823116 Homo sapiens Alpha-1-antitrypsin Proteins 0.000 description 3
• 101000873111 Homo sapiens Vesicle transport protein SEC20 Proteins 0.000 description 3
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 3
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 3
• ZCYVEMRRCGMTRW-AHCXROLUSA-N Iodine-123 Chemical compound [123I] ZCYVEMRRCGMTRW-AHCXROLUSA-N 0.000 description 3
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
• 206010027406 Mesothelioma Diseases 0.000 description 3
• 238000012408 PCR amplification Methods 0.000 description 3
• 102100039277 Pleiotrophin Human genes 0.000 description 3
• 108091006629 SLC13A2 Proteins 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 3
• 102100027212 Tumor-associated calcium signal transducer 2 Human genes 0.000 description 3
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
• 102100035030 Vesicle transport protein SEC20 Human genes 0.000 description 3
• 230000021736 acetylation Effects 0.000 description 3
• 238000006640 acetylation reaction Methods 0.000 description 3
• 230000002776 aggregation Effects 0.000 description 3
• 238000004220 aggregation Methods 0.000 description 3
• 238000013103 analytical ultracentrifugation Methods 0.000 description 3
• 238000000668 atmospheric pressure chemical ionisation mass spectrometry Methods 0.000 description 3
• 238000001854 atmospheric pressure photoionisation mass spectrometry Methods 0.000 description 3
• 238000013276 bronchoscopy Methods 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 230000001186 cumulative effect Effects 0.000 description 3
• 230000018044 dehydration Effects 0.000 description 3
• 238000006297 dehydration reaction Methods 0.000 description 3
• 238000010790 dilution Methods 0.000 description 3
• 239000012895 dilution Substances 0.000 description 3
• 238000010494 dissociation reaction Methods 0.000 description 3
• 230000005593 dissociations Effects 0.000 description 3
• 238000001035 drying Methods 0.000 description 3
• 230000008030 elimination Effects 0.000 description 3
• 238000003379 elimination reaction Methods 0.000 description 3
• 230000006862 enzymatic digestion Effects 0.000 description 3
• 239000011888 foil Substances 0.000 description 3
• 238000005194 fractionation Methods 0.000 description 3
• 125000000524 functional group Chemical group 0.000 description 3
• 238000011223 gene expression profiling Methods 0.000 description 3
• 230000013595 glycosylation Effects 0.000 description 3
• 238000006206 glycosylation reaction Methods 0.000 description 3
• 230000003862 health status Effects 0.000 description 3
• 238000012744 immunostaining Methods 0.000 description 3
• 230000006872 improvement Effects 0.000 description 3
• 238000000370 laser capture micro-dissection Methods 0.000 description 3
• 210000000265 leukocyte Anatomy 0.000 description 3
• 238000007885 magnetic separation Methods 0.000 description 3
• 239000006148 magnetic separator Substances 0.000 description 3
• 238000007726 management method Methods 0.000 description 3
• 238000005374 membrane filtration Methods 0.000 description 3
• 238000002156 mixing Methods 0.000 description 3
• 238000007837 multiplex assay Methods 0.000 description 3
• 229920000747 poly(lactic acid) Polymers 0.000 description 3
• 239000004417 polycarbonate Substances 0.000 description 3
• 238000011176 pooling Methods 0.000 description 3
• 238000004393 prognosis Methods 0.000 description 3
• 238000011002 quantification Methods 0.000 description 3
• 239000002096 quantum dot Substances 0.000 description 3
• 230000002285 radioactive effect Effects 0.000 description 3
• 238000001959 radiotherapy Methods 0.000 description 3
• 102000005962 receptors Human genes 0.000 description 3
• 108020003175 receptors Proteins 0.000 description 3
• 230000001105 regulatory effect Effects 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 238000002271 resection Methods 0.000 description 3
• 238000003757 reverse transcription PCR Methods 0.000 description 3
• 150000003384 small molecules Chemical class 0.000 description 3
• 238000002791 soaking Methods 0.000 description 3
• 125000006850 spacer group Chemical group 0.000 description 3
• 230000009870 specific binding Effects 0.000 description 3
• 206010041823 squamous cell carcinoma Diseases 0.000 description 3
• 238000013179 statistical model Methods 0.000 description 3
• 229940056501 technetium 99m Drugs 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• 239000011534 wash buffer Substances 0.000 description 3
• WHVNXSBKJGAXKU-UHFFFAOYSA-N Alexa Fluor 532 Chemical compound [H+].[H+].CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)N=4)(C)C)=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C=C1)=CC=C1C(=O)ON1C(=O)CCC1=O WHVNXSBKJGAXKU-UHFFFAOYSA-N 0.000 description 2
• 108010049777 Ankyrins Proteins 0.000 description 2
• 102000008102 Ankyrins Human genes 0.000 description 2
• 108010031480 Artificial Receptors Proteins 0.000 description 2
• 238000012935 Averaging Methods 0.000 description 2
• 102100025440 BMP-binding endothelial regulator protein Human genes 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• 101150023103 CHI gene Proteins 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• 102100026540 Cathepsin L2 Human genes 0.000 description 2
• 108091006146 Channels Proteins 0.000 description 2
• 206010009944 Colon cancer Diseases 0.000 description 2
• 102100037068 Cytoplasmic dynein 1 light intermediate chain 1 Human genes 0.000 description 2
• 238000000018 DNA microarray Methods 0.000 description 2
• 206010061818 Disease progression Diseases 0.000 description 2
• 206010061819 Disease recurrence Diseases 0.000 description 2
• 238000004252 FT/ICR mass spectrometry Methods 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• 101000934632 Homo sapiens BMP-binding endothelial regulator protein Proteins 0.000 description 2
• 101000983577 Homo sapiens Cathepsin L2 Proteins 0.000 description 2
• 101000940068 Homo sapiens Collagen alpha-1(XVIII) chain Proteins 0.000 description 2
• 101000954692 Homo sapiens Cytoplasmic dynein 1 light intermediate chain 1 Proteins 0.000 description 2
• 101001044940 Homo sapiens Insulin-like growth factor-binding protein 2 Proteins 0.000 description 2
• 101000760817 Homo sapiens Macrophage-capping protein Proteins 0.000 description 2
• 101001091365 Homo sapiens Plasma kallikrein Proteins 0.000 description 2
• 101000605534 Homo sapiens Prostate-specific antigen Proteins 0.000 description 2
• 101000994496 Homo sapiens cAMP-dependent protein kinase catalytic subunit alpha Proteins 0.000 description 2
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
• 102100022710 Insulin-like growth factor-binding protein 2 Human genes 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• 108090001090 Lectins Proteins 0.000 description 2
• 102000004856 Lectins Human genes 0.000 description 2
• 102100024573 Macrophage-capping protein Human genes 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 101710163270 Nuclease Proteins 0.000 description 2
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
• 102000003992 Peroxidases Human genes 0.000 description 2
• 206010035603 Pleural mesothelioma Diseases 0.000 description 2
• 102100038358 Prostate-specific antigen Human genes 0.000 description 2
• 238000011529 RT qPCR Methods 0.000 description 2
• 108010003723 Single-Domain Antibodies Proteins 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• 108700012457 TACSTD2 Proteins 0.000 description 2
• 102000014456 Trefoil Factor-3 Human genes 0.000 description 2
• 108010078184 Trefoil Factor-3 Proteins 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• IVCWGAIYDLMKAJ-UHFFFAOYSA-N [4-(1-decylpiperidine-3-carbonyl)piperazin-1-yl]-(1-decylpiperidin-3-yl)methanone Chemical compound C1N(CCCCCCCCCC)CCCC1C(=O)N1CCN(C(=O)C2CN(CCCCCCCCCC)CCC2)CC1 IVCWGAIYDLMKAJ-UHFFFAOYSA-N 0.000 description 2
• 108091022873 acetoacetate decarboxylase Proteins 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 208000009956 adenocarcinoma Diseases 0.000 description 2
• MGSKVZWGBWPBTF-UHFFFAOYSA-N aebsf Chemical compound NCCC1=CC=C(S(F)(=O)=O)C=C1 MGSKVZWGBWPBTF-UHFFFAOYSA-N 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 230000003466 anti-cipated effect Effects 0.000 description 2
• 239000000427 antigen Substances 0.000 description 2
• 108091007433 antigens Proteins 0.000 description 2
• 102000036639 antigens Human genes 0.000 description 2
• 238000003491 array Methods 0.000 description 2
• 239000010425 asbestos Substances 0.000 description 2
• 230000001174 ascending effect Effects 0.000 description 2
• 125000004429 atom Chemical group 0.000 description 2
• 238000013476 bayesian approach Methods 0.000 description 2
• 235000013527 bean curd Nutrition 0.000 description 2
• 230000005540 biological transmission Effects 0.000 description 2
• 238000005415 bioluminescence Methods 0.000 description 2
• 230000029918 bioluminescence Effects 0.000 description 2
• 238000006664 bond formation reaction Methods 0.000 description 2
• 210000000481 breast Anatomy 0.000 description 2
• 230000001680 brushing effect Effects 0.000 description 2
• 229920005549 butyl rubber Polymers 0.000 description 2
• 102100032791 cAMP-dependent protein kinase catalytic subunit alpha Human genes 0.000 description 2
• 238000005251 capillar electrophoresis Methods 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 238000005119 centrifugation Methods 0.000 description 2
• 238000012512 characterization method Methods 0.000 description 2
• 238000011976 chest X-ray Methods 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 208000029742 colonic neoplasm Diseases 0.000 description 2
• 239000002299 complementary DNA Substances 0.000 description 2
• 150000001875 compounds Chemical class 0.000 description 2
• 239000003636 conditioned culture medium Substances 0.000 description 2
• 230000021615 conjugation Effects 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 102000003675 cytokine receptors Human genes 0.000 description 2
• 108010057085 cytokine receptors Proteins 0.000 description 2
• 210000000805 cytoplasm Anatomy 0.000 description 2
• 238000007405 data analysis Methods 0.000 description 2
• 238000007418 data mining Methods 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 230000009274 differential gene expression Effects 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 238000007865 diluting Methods 0.000 description 2
• 230000005750 disease progression Effects 0.000 description 2
• 239000012153 distilled water Substances 0.000 description 2
• 238000013399 early diagnosis Methods 0.000 description 2
• 238000010828 elution Methods 0.000 description 2
• 210000003743 erythrocyte Anatomy 0.000 description 2
• DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 238000010195 expression analysis Methods 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• 238000007710 freezing Methods 0.000 description 2
• 230000008014 freezing Effects 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 150000004676 glycans Polymers 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 108091008039 hormone receptors Proteins 0.000 description 2
• 101150017578 hrdl-1 gene Proteins 0.000 description 2
• 230000003100 immobilizing effect Effects 0.000 description 2
• 238000001114 immunoprecipitation Methods 0.000 description 2
• 238000007901 in situ hybridization Methods 0.000 description 2
• 230000008595 infiltration Effects 0.000 description 2
• 238000001764 infiltration Methods 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 239000002523 lectin Substances 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 230000029226 lipidation Effects 0.000 description 2
• 230000004807 localization Effects 0.000 description 2
• 208000037841 lung tumor Diseases 0.000 description 2
• 229910001629 magnesium chloride Inorganic materials 0.000 description 2
• 238000002595 magnetic resonance imaging Methods 0.000 description 2
• 238000004519 manufacturing process Methods 0.000 description 2
• 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
• 239000002207 metabolite Substances 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 238000001531 micro-dissection Methods 0.000 description 2
• 238000012821 model calculation Methods 0.000 description 2
• 239000012120 mounting media Substances 0.000 description 2
• 239000013642 negative control Substances 0.000 description 2
• 239000002853 nucleic acid probe Substances 0.000 description 2
• 238000003203 nucleic acid sequencing method Methods 0.000 description 2
• 238000012634 optical imaging Methods 0.000 description 2
• 238000005457 optimization Methods 0.000 description 2
• 230000002018 overexpression Effects 0.000 description 2
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
• 230000003076 paracrine Effects 0.000 description 2
• 239000000816 peptidomimetic Substances 0.000 description 2
• 108040007629 peroxidase activity proteins Proteins 0.000 description 2
• 230000026731 phosphorylation Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 230000035790 physiological processes and functions Effects 0.000 description 2
• 210000004910 pleural fluid Anatomy 0.000 description 2
• 239000005017 polysaccharide Substances 0.000 description 2
• 238000001556 precipitation Methods 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 230000002035 prolonged effect Effects 0.000 description 2
• WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
• 230000005855 radiation Effects 0.000 description 2
• 238000003753 real-time PCR Methods 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 229910052895 riebeckite Inorganic materials 0.000 description 2
• 238000005096 rolling process Methods 0.000 description 2
• 239000012898 sample dilution Substances 0.000 description 2
• 238000007790 scraping Methods 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 238000010187 selection method Methods 0.000 description 2
• 238000003196 serial analysis of gene expression Methods 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• 239000000377 silicon dioxide Substances 0.000 description 2
• 239000000779 smoke Substances 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 238000000638 solvent extraction Methods 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 239000011550 stock solution Substances 0.000 description 2
• 108010051423 streptavidin-agarose Proteins 0.000 description 2
• 230000000153 supplemental effect Effects 0.000 description 2
• 238000010189 synthetic method Methods 0.000 description 2
• 230000009897 systematic effect Effects 0.000 description 2
• UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• 238000000539 two dimensional gel electrophoresis Methods 0.000 description 2
• 210000002700 urine Anatomy 0.000 description 2
• YMXHPSHLTSZXKH-RVBZMBCESA-N (2,5-dioxopyrrolidin-1-yl) 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)ON1C(=O)CCC1=O YMXHPSHLTSZXKH-RVBZMBCESA-N 0.000 description 1
• NDVRKEKNSBMTAX-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O NDVRKEKNSBMTAX-BTVCFUMJSA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• CBXRMKZFYQISIV-UHFFFAOYSA-N 1-n,1-n,1-n',1-n',2-n,2-n,2-n',2-n'-octamethylethene-1,1,2,2-tetramine Chemical group CN(C)C(N(C)C)=C(N(C)C)N(C)C CBXRMKZFYQISIV-UHFFFAOYSA-N 0.000 description 1
• PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 1
• 102100024682 14-3-3 protein eta Human genes 0.000 description 1
• 101710188276 14-3-3 protein eta Proteins 0.000 description 1
• INEWUCPYEUEQTN-UHFFFAOYSA-N 3-(cyclohexylamino)-2-hydroxy-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CNC1CCCCC1 INEWUCPYEUEQTN-UHFFFAOYSA-N 0.000 description 1
• QMGUOJYZJKLOLH-UHFFFAOYSA-N 3-[1-[3-(dimethylamino)propyl]indol-3-yl]-4-(1h-indol-3-yl)pyrrole-2,5-dione Chemical compound C12=CC=CC=C2N(CCCN(C)C)C=C1C1=C(C=2C3=CC=CC=C3NC=2)C(=O)NC1=O QMGUOJYZJKLOLH-UHFFFAOYSA-N 0.000 description 1
• 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
• 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
• MPVDXIMFBOLMNW-ISLYRVAYSA-N 7-hydroxy-8-[(E)-phenyldiazenyl]naphthalene-1,3-disulfonic acid Chemical compound OC1=CC=C2C=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C2=C1\N=N\C1=CC=CC=C1 MPVDXIMFBOLMNW-ISLYRVAYSA-N 0.000 description 1
• 244000178606 Abies grandis Species 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 239000012103 Alexa Fluor 488 Substances 0.000 description 1
• 239000012114 Alexa Fluor 647 Substances 0.000 description 1
• 239000012116 Alexa Fluor 680 Substances 0.000 description 1
• 239000012117 Alexa Fluor 700 Substances 0.000 description 1
• 239000012099 Alexa Fluor family Substances 0.000 description 1
• 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
• QGZKDVFQNNGYKY-OUBTZVSYSA-N Ammonia-15N Chemical compound [15NH3] QGZKDVFQNNGYKY-OUBTZVSYSA-N 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• 101100439253 Arabidopsis thaliana CHI3 gene Proteins 0.000 description 1
• 101100351614 Arabidopsis thaliana PER34 gene Proteins 0.000 description 1
• 101150036934 Arhgef25 gene Proteins 0.000 description 1
• 206010003445 Ascites Diseases 0.000 description 1
• 102100026292 Asialoglycoprotein receptor 1 Human genes 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 108091032955 Bacterial small RNA Proteins 0.000 description 1
• 102100031006 Beta-Ala-His dipeptidase Human genes 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
• 102100028728 Bone morphogenetic protein 1 Human genes 0.000 description 1
• 102000000905 Cadherin Human genes 0.000 description 1
• 108050007957 Cadherin Proteins 0.000 description 1
• 101100004286 Caenorhabditis elegans best-5 gene Proteins 0.000 description 1
• 101100341170 Caenorhabditis elegans irg-7 gene Proteins 0.000 description 1
• 101100194816 Caenorhabditis elegans rig-3 gene Proteins 0.000 description 1
• 102100033868 Cannabinoid receptor 1 Human genes 0.000 description 1
• 101710187010 Cannabinoid receptor 1 Proteins 0.000 description 1
• 244000025254 Cannabis sativa Species 0.000 description 1
• 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
• 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
• OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 206010008479 Chest Pain Diseases 0.000 description 1
• 101000986346 Chironomus tentans High mobility group protein I Proteins 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 108090000227 Chymases Proteins 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 241000207199 Citrus Species 0.000 description 1
• 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
• 108010087195 Contactin 1 Proteins 0.000 description 1
• 229920000742 Cotton Polymers 0.000 description 1
• 206010011224 Cough Diseases 0.000 description 1
• 239000003154 D dimer Substances 0.000 description 1
• 102100037579 D-3-phosphoglycerate dehydrogenase Human genes 0.000 description 1
• IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
• LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical group OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 101100161150 Danio rerio ywhag1 gene Proteins 0.000 description 1
• CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
• 101001112318 Dictyostelium discoideum Nucleoside diphosphate kinase, cytosolic Proteins 0.000 description 1
• 101001112320 Dictyostelium discoideum Nucleoside diphosphate kinase, mitochondrial Proteins 0.000 description 1
• 206010013710 Drug interaction Diseases 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 206010063045 Effusion Diseases 0.000 description 1
• 108010044063 Endocrine-Gland-Derived Vascular Endothelial Growth Factor Proteins 0.000 description 1
• 108010079505 Endostatins Proteins 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 102100037362 Fibronectin Human genes 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
• 229910052688 Gadolinium Inorganic materials 0.000 description 1
• 108010015133 Galactose oxidase Proteins 0.000 description 1
• 206010056740 Genital discharge Diseases 0.000 description 1
• 101100447189 Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) FSL2 gene Proteins 0.000 description 1
• 241000948258 Gila Species 0.000 description 1
• 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
• 102100022624 Glucoamylase Human genes 0.000 description 1
• 108010015776 Glucose oxidase Proteins 0.000 description 1
• 239000004366 Glucose oxidase Substances 0.000 description 1
• 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
• 101100171978 Glycine max TUFB1 gene Proteins 0.000 description 1
• 229920002527 Glycogen Polymers 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 102100020948 Growth hormone receptor Human genes 0.000 description 1
• 102100025255 Haptoglobin Human genes 0.000 description 1
• 108050005077 Haptoglobin Proteins 0.000 description 1
• 244000043261 Hevea brasiliensis Species 0.000 description 1
• 101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 description 1
• 101000785944 Homo sapiens Asialoglycoprotein receptor 1 Proteins 0.000 description 1
• 101000919694 Homo sapiens Beta-Ala-His dipeptidase Proteins 0.000 description 1
• 101000714525 Homo sapiens Carbonic anhydrase 6 Proteins 0.000 description 1
• 101001075287 Homo sapiens Growth hormone receptor Proteins 0.000 description 1
• 101001064282 Homo sapiens Platelet-activating factor acetylhydrolase IB subunit beta Proteins 0.000 description 1
• 101001128731 Homo sapiens Putative nucleoside diphosphate kinase Proteins 0.000 description 1
• 101000798007 Homo sapiens RAC-gamma serine/threonine-protein kinase Proteins 0.000 description 1
• 101000697800 Homo sapiens Syntaxin-4 Proteins 0.000 description 1
• 101000848014 Homo sapiens Trypsin-2 Proteins 0.000 description 1
• 101000760337 Homo sapiens Urokinase plasminogen activator surface receptor Proteins 0.000 description 1
• 101150085452 IPT1 gene Proteins 0.000 description 1
• 238000004566 IR spectroscopy Methods 0.000 description 1
• HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
• 108010076876 Keratins Proteins 0.000 description 1
• 102000011782 Keratins Human genes 0.000 description 1
• 238000007397 LAMP assay Methods 0.000 description 1
• 238000012773 Laboratory assay Methods 0.000 description 1
• 241000272168 Laridae Species 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
• 102000014944 Lysosome-Associated Membrane Glycoproteins Human genes 0.000 description 1
• 108010064171 Lysosome-Associated Membrane Glycoproteins Proteins 0.000 description 1
• 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
• PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
• 108090000855 Matrilysin Proteins 0.000 description 1
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
• 238000007476 Maximum Likelihood Methods 0.000 description 1
• 101100439240 Medicago sativa CHI1 gene Proteins 0.000 description 1
• 108060004795 Methyltransferase Proteins 0.000 description 1
• 108700011259 MicroRNAs Proteins 0.000 description 1
• 102000016943 Muramidase Human genes 0.000 description 1
• 108010014251 Muramidase Proteins 0.000 description 1
• 101100500508 Mus musculus Ebpl gene Proteins 0.000 description 1
• 101100533558 Mus musculus Sipa1 gene Proteins 0.000 description 1
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
• 238000005481 NMR spectroscopy Methods 0.000 description 1
• 101100093389 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) crp-7 gene Proteins 0.000 description 1
• 101100251238 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) crp-79 gene Proteins 0.000 description 1
• 244000061176 Nicotiana tabacum Species 0.000 description 1
• 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
• 101100495510 Nicotiana tabacum CHI gene Proteins 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• QJGQUHMNIGDVPM-BJUDXGSMSA-N Nitrogen-13 Chemical compound [13N] QJGQUHMNIGDVPM-BJUDXGSMSA-N 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 108091028043 Nucleic acid sequence Proteins 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 206010073310 Occupational exposures Diseases 0.000 description 1
• 108090000854 Oxidoreductases Proteins 0.000 description 1
• 102000004316 Oxidoreductases Human genes 0.000 description 1
• 229910019142 PO4 Chemical group 0.000 description 1
• 241000282320 Panthera leo Species 0.000 description 1
• 108091093037 Peptide nucleic acid Proteins 0.000 description 1
• 108010043958 Peptoids Proteins 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 241000158500 Platanus racemosa Species 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 239000004743 Polypropylene Substances 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 102100040126 Prokineticin-1 Human genes 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 108010026552 Proteome Proteins 0.000 description 1
• 102100032116 Putative nucleoside diphosphate kinase Human genes 0.000 description 1
• 108010066717 Q beta Replicase Proteins 0.000 description 1
• 102100032314 RAC-gamma serine/threonine-protein kinase Human genes 0.000 description 1
• 238000001069 Raman spectroscopy Methods 0.000 description 1
• 101100130647 Rattus norvegicus Mmp7 gene Proteins 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 208000021063 Respiratory fume inhalation disease Diseases 0.000 description 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
• 101150109818 STU1 gene Proteins 0.000 description 1
• 101100065705 Schizosaccharomyces pombe (strain 972 / ATCC 24843) etd1 gene Proteins 0.000 description 1
• 241000543375 Sideroxylon Species 0.000 description 1
• BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
• XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 101100118623 Solanum lycopersicum EIX1 gene Proteins 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 102100030511 Stanniocalcin-1 Human genes 0.000 description 1
• 102000013265 Syntaxin 1 Human genes 0.000 description 1
• 108010090618 Syntaxin 1 Proteins 0.000 description 1
• 102100027975 Syntaxin-4 Human genes 0.000 description 1
• 108091046915 Threose nucleic acid Proteins 0.000 description 1
• 235000011941 Tilia x europaea Nutrition 0.000 description 1
• 101710194411 Triosephosphate isomerase 1 Proteins 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 102100034392 Trypsin-2 Human genes 0.000 description 1
• 108010092464 Urate Oxidase Proteins 0.000 description 1
• 108010046334 Urease Proteins 0.000 description 1
• 102100024689 Urokinase plasminogen activator surface receptor Human genes 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• 108010093894 Xanthine oxidase Proteins 0.000 description 1
• 102100033220 Xanthine oxidase Human genes 0.000 description 1
• 101150083738 YWHAG gene Proteins 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• 239000002250 absorbent Substances 0.000 description 1
• 230000002745 absorbent Effects 0.000 description 1
• KRHYYFGTRYWZRS-BJUDXGSMSA-N ac1l2y5h Chemical compound [18FH] KRHYYFGTRYWZRS-BJUDXGSMSA-N 0.000 description 1
• 230000001133 acceleration Effects 0.000 description 1
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 230000002730 additional effect Effects 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 230000004520 agglutination Effects 0.000 description 1
• 238000003915 air pollution Methods 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 108010004469 allophycocyanin Proteins 0.000 description 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 210000004381 amniotic fluid Anatomy 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 238000013528 artificial neural network Methods 0.000 description 1
• 230000000712 assembly Effects 0.000 description 1
• 238000000429 assembly Methods 0.000 description 1
• 238000004630 atomic force microscopy Methods 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 239000000091 biomarker candidate Substances 0.000 description 1
• 239000002981 blocking agent Substances 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 208000024753 bloody sputum Diseases 0.000 description 1
• 238000009835 boiling Methods 0.000 description 1
• 206010006451 bronchitis Diseases 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 235000009120 camo Nutrition 0.000 description 1
• 239000012830 cancer therapeutic Substances 0.000 description 1
• 238000009566 cancer vaccine Methods 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 108010019521 carbonic anhydrase VI Proteins 0.000 description 1
• 231100000357 carcinogen Toxicity 0.000 description 1
• 239000003183 carcinogenic agent Substances 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
• 235000005607 chanvre indien Nutrition 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 238000003392 chemiluminescence resonance energy transfer Methods 0.000 description 1
• PRQROPMIIGLWRP-BZSNNMDCSA-N chemotactic peptide Chemical class CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-BZSNNMDCSA-N 0.000 description 1
• 239000003593 chromogenic compound Substances 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 235000019504 cigarettes Nutrition 0.000 description 1
• 210000004081 cilia Anatomy 0.000 description 1
• 235000020971 citrus fruits Nutrition 0.000 description 1
• 210000000078 claw Anatomy 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 238000005345 coagulation Methods 0.000 description 1
• 230000015271 coagulation Effects 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 238000010411 cooking Methods 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 238000005520 cutting process Methods 0.000 description 1
• 230000003583 cytomorphological effect Effects 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
• 238000013480 data collection Methods 0.000 description 1
• 238000003066 decision tree Methods 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 239000000104 diagnostic biomarker Substances 0.000 description 1
• 238000002059 diagnostic imaging Methods 0.000 description 1
• 239000012502 diagnostic product Substances 0.000 description 1
• 210000000188 diaphragm Anatomy 0.000 description 1
• FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 239000013024 dilution buffer Substances 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• 230000003828 downregulation Effects 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 238000002651 drug therapy Methods 0.000 description 1
• 238000000835 electrochemical detection Methods 0.000 description 1
• 238000011209 electrochromatography Methods 0.000 description 1
• 230000005264 electron capture Effects 0.000 description 1
• 238000000295 emission spectrum Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
• SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
• 239000006167 equilibration buffer Substances 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 210000002744 extracellular matrix Anatomy 0.000 description 1
• 238000005562 fading Methods 0.000 description 1
• 235000013861 fat-free Nutrition 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 230000012953 feeding on blood of other organism Effects 0.000 description 1
• 108010052295 fibrin fragment D Proteins 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 238000007667 floating Methods 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 238000002875 fluorescence polarization Methods 0.000 description 1
• 238000001506 fluorescence spectroscopy Methods 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
• 230000005251 gamma ray Effects 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
• 230000000762 glandular Effects 0.000 description 1
• 229940116332 glucose oxidase Drugs 0.000 description 1
• 235000019420 glucose oxidase Nutrition 0.000 description 1
• 229940096919 glycogen Drugs 0.000 description 1
• 239000005337 ground glass Substances 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 229960000789 guanidine hydrochloride Drugs 0.000 description 1
• PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
• ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
• 239000011487 hemp Substances 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 238000003365 immunocytochemistry Methods 0.000 description 1
• 238000011532 immunohistochemical staining Methods 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 238000007373 indentation Methods 0.000 description 1
• APFVFJFRJDLVQX-AHCXROLUSA-N indium-111 Chemical compound [111In] APFVFJFRJDLVQX-AHCXROLUSA-N 0.000 description 1
• 229940055742 indium-111 Drugs 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 229910010272 inorganic material Inorganic materials 0.000 description 1
• 239000011147 inorganic material Substances 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000005040 ion trap Methods 0.000 description 1
• 238000000534 ion trap mass spectrometry Methods 0.000 description 1
• 230000005865 ionizing radiation Effects 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 238000001948 isotopic labelling Methods 0.000 description 1
• 208000003849 large cell carcinoma Diseases 0.000 description 1
• 238000001001 laser micro-dissection Methods 0.000 description 1
• 238000007834 ligase chain reaction Methods 0.000 description 1
• 239000004571 lime Substances 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 238000004811 liquid chromatography Methods 0.000 description 1
• MHCFAGZWMAWTNR-UHFFFAOYSA-M lithium perchlorate Chemical compound [Li+].[O-]Cl(=O)(=O)=O MHCFAGZWMAWTNR-UHFFFAOYSA-M 0.000 description 1
• 229910001486 lithium perchlorate Inorganic materials 0.000 description 1
• UPRXAOPZPSAYHF-UHFFFAOYSA-N lithium;cyclohexyl(propan-2-yl)azanide Chemical compound CC(C)N([Li])C1CCCCC1 UPRXAOPZPSAYHF-UHFFFAOYSA-N 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• KNJDBYZZKAZQNG-UHFFFAOYSA-N lucigenin Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.C12=CC=CC=C2[N+](C)=C(C=CC=C2)C2=C1C1=C(C=CC=C2)C2=[N+](C)C2=CC=CC=C12 KNJDBYZZKAZQNG-UHFFFAOYSA-N 0.000 description 1
• 238000004020 luminiscence type Methods 0.000 description 1
• 210000004880 lymph fluid Anatomy 0.000 description 1
• 229960000274 lysozyme Drugs 0.000 description 1
• 239000004325 lysozyme Substances 0.000 description 1
• 235000010335 lysozyme Nutrition 0.000 description 1
• 238000010801 machine learning Methods 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 239000006249 magnetic particle Substances 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 229910052748 manganese Inorganic materials 0.000 description 1
• 239000011572 manganese Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 108010029942 microperoxidase Proteins 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 210000003097 mucus Anatomy 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 238000011512 multiplexed immunoassay Methods 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 229920003052 natural elastomer Polymers 0.000 description 1
• 229920001194 natural rubber Polymers 0.000 description 1
• 238000013188 needle biopsy Methods 0.000 description 1
• 238000004848 nephelometry Methods 0.000 description 1
• 238000006386 neutralization reaction Methods 0.000 description 1
• 108010087904 neutravidin Proteins 0.000 description 1
• 210000002445 nipple Anatomy 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 238000010606 normalization Methods 0.000 description 1
• 108091008104 nucleic acid aptamers Proteins 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• 231100000675 occupational exposure Toxicity 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 239000000382 optic material Substances 0.000 description 1
• 239000011368 organic material Substances 0.000 description 1
• 239000012285 osmium tetroxide Substances 0.000 description 1
• 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
• QVGXLLKOCUKJST-BJUDXGSMSA-N oxygen-15 atom Chemical compound [15O] QVGXLLKOCUKJST-BJUDXGSMSA-N 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 238000009595 pap smear Methods 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 239000000863 peptide conjugate Substances 0.000 description 1
• 229940086255 perform Drugs 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical group [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Chemical group 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
• 239000000902 placebo Substances 0.000 description 1
• 229940068196 placebo Drugs 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 231100000614 poison Toxicity 0.000 description 1
• 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
• 229920002239 polyacrylonitrile Polymers 0.000 description 1
• 229920000515 polycarbonate Polymers 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 230000000379 polymerizing effect Effects 0.000 description 1
• 239000004926 polymethyl methacrylate Substances 0.000 description 1
• 239000011116 polymethylpentene Substances 0.000 description 1
• 229920000306 polymethylpentene Polymers 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 150000004804 polysaccharides Polymers 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
• 239000004810 polytetrafluoroethylene Substances 0.000 description 1
• 239000004800 polyvinyl chloride Substances 0.000 description 1
• 229920000915 polyvinyl chloride Polymers 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 238000010837 poor prognosis Methods 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 238000004321 preservation Methods 0.000 description 1
• 230000002250 progressing effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 239000012460 protein solution Substances 0.000 description 1
• 230000004850 protein–protein interaction Effects 0.000 description 1
• 238000010384 proximity ligation assay Methods 0.000 description 1
• 150000003230 pyrimidines Chemical group 0.000 description 1
• 229940079877 pyrogallol Drugs 0.000 description 1
• 238000005173 quadrupole mass spectroscopy Methods 0.000 description 1
• 238000004445 quantitative analysis Methods 0.000 description 1
• 238000010833 quantitative mass spectrometry Methods 0.000 description 1
• 239000000700 radioactive tracer Substances 0.000 description 1
• 229910052704 radon Inorganic materials 0.000 description 1
• SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
• 229910052761 rare earth metal Inorganic materials 0.000 description 1
• 150000002910 rare earth metals Chemical class 0.000 description 1
• 230000035484 reaction time Effects 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 239000012488 sample solution Substances 0.000 description 1
• 238000005070 sampling Methods 0.000 description 1
• 229930182490 saponin Natural products 0.000 description 1
• 235000017709 saponins Nutrition 0.000 description 1
• 150000007949 saponins Chemical class 0.000 description 1
• 238000013077 scoring method Methods 0.000 description 1
• 238000001004 secondary ion mass spectrometry Methods 0.000 description 1
• 210000000582 semen Anatomy 0.000 description 1
• 229910000077 silane Inorganic materials 0.000 description 1
• 150000003376 silicon Chemical class 0.000 description 1
• 229910052710 silicon Inorganic materials 0.000 description 1
• 239000010703 silicon Substances 0.000 description 1
• 238000002922 simulated annealing Methods 0.000 description 1
• 201000010106 skin squamous cell carcinoma Diseases 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• 239000011343 solid material Substances 0.000 description 1
• 239000011537 solubilization buffer Substances 0.000 description 1
• 238000002798 spectrophotometry method Methods 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 238000013517 stratification Methods 0.000 description 1
• 229920003048 styrene butadiene rubber Polymers 0.000 description 1
• 210000004895 subcellular structure Anatomy 0.000 description 1
• 230000002311 subsequent effect Effects 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 238000012706 support-vector machine Methods 0.000 description 1
• 238000010897 surface acoustic wave method Methods 0.000 description 1
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
• 210000001179 synovial fluid Anatomy 0.000 description 1
• 229920002994 synthetic fiber Polymers 0.000 description 1
• 210000001138 tear Anatomy 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 150000003505 terpenes Chemical class 0.000 description 1
• 235000007586 terpenes Nutrition 0.000 description 1
• BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
• VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 1
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
• 229940022511 therapeutic cancer vaccine Drugs 0.000 description 1
• 238000011285 therapeutic regimen Methods 0.000 description 1
• 210000000779 thoracic wall Anatomy 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
• 238000001776 time-resolved fluorescence quenching Methods 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 239000003440 toxic substance Substances 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 239000012588 trypsin Substances 0.000 description 1
• 239000002753 trypsin inhibitor Substances 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 230000005641 tunneling Effects 0.000 description 1
• 230000009452 underexpressoin Effects 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 229920002554 vinyl polymer Polymers 0.000 description 1
• 238000011179 visual inspection Methods 0.000 description 1
• 238000012800 visualization Methods 0.000 description 1
• XLYOFNOQVPJJNP-OUBTZVSYSA-N water-17o Chemical compound [17OH2] XLYOFNOQVPJJNP-OUBTZVSYSA-N 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 210000002268 wool Anatomy 0.000 description 1
• 230000003936 working memory Effects 0.000 description 1
• 239000012224 working solution Substances 0.000 description 1